296 related articles for article (PubMed ID: 11423572)
41. Microvasculature change and placenta growth factor expression in the early stage of a rat remnant kidney model.
Wu Q; Du Y; Yang N; Liang Y; Li Y
Am J Nephrol; 2006; 26(1):97-104. PubMed ID: 16543713
[TBL] [Abstract][Full Text] [Related]
42. Opposing effects of hypoxia on expression of the angiogenic inhibitor thrombospondin 1 and the angiogenic inducer vascular endothelial growth factor.
Laderoute KR; Alarcon RM; Brody MD; Calaoagan JM; Chen EY; Knapp AM; Yun Z; Denko NC; Giaccia AJ
Clin Cancer Res; 2000 Jul; 6(7):2941-50. PubMed ID: 10914744
[TBL] [Abstract][Full Text] [Related]
43. Activation of VEGF and Ras genes in gastric mucosa during angiogenic response to ethanol injury.
Jones MK; Itani RM; Wang H; Tomikawa M; Sarfeh IJ; Szabo S; Tarnawski AS
Am J Physiol; 1999 Jun; 276(6):G1345-55. PubMed ID: 10362637
[TBL] [Abstract][Full Text] [Related]
44. Vascular endothelial growth factor accelerates renal recovery in experimental thrombotic microangiopathy.
Kim YG; Suga SI; Kang DH; Jefferson JA; Mazzali M; Gordon KL; Matsui K; Breiteneder-Geleff S; Shankland SJ; Hughes J; Kerjaschki D; Schreiner GF; Johnson RJ
Kidney Int; 2000 Dec; 58(6):2390-9. PubMed ID: 11115072
[TBL] [Abstract][Full Text] [Related]
45. Angiogenesis and vascular endothelial growth factor (VEGF): is it relevant in renal patients?
Gröne HJ
Nephrol Dial Transplant; 1995; 10(6):761-3. PubMed ID: 7566598
[No Abstract] [Full Text] [Related]
46. Vascular endothelial growth factor mediated angiogenic potential of pancreatic ductal carcinomas enhanced by hypoxia: an in vitro and in vivo study.
Sipos B; Weber D; Ungefroren H; Kalthoff H; Zühlsdorff A; Luther C; Török V; Klöppel G
Int J Cancer; 2002 Dec; 102(6):592-600. PubMed ID: 12448000
[TBL] [Abstract][Full Text] [Related]
47. Exercise and insulin-like growth factor 1 supplementation improve angiogenesis and angiogenic cytokines in a rat model of diabetes-induced neuropathy.
Saboory E; Gholizadeh-Ghaleh Aziz S; Samadi M; Biabanghard A; Chodari L
Exp Physiol; 2020 May; 105(5):783-792. PubMed ID: 32053260
[TBL] [Abstract][Full Text] [Related]
48. Inhibition of endogenous VEGF impedes revascularization and astroglial proliferation: roles for VEGF in brain repair.
Krum JM; Khaibullina A
Exp Neurol; 2003 Jun; 181(2):241-57. PubMed ID: 12781997
[TBL] [Abstract][Full Text] [Related]
49. VEGF: an update on biological and therapeutic aspects.
Ferrara N
Curr Opin Biotechnol; 2000 Dec; 11(6):617-24. PubMed ID: 11102799
[TBL] [Abstract][Full Text] [Related]
50. Expression of the oxygen-regulated protein ORP150 accelerates wound healing by modulating intracellular VEGF transport.
Ozawa K; Kondo T; Hori O; Kitao Y; Stern DM; Eisenmenger W; Ogawa S; Ohshima T
J Clin Invest; 2001 Jul; 108(1):41-50. PubMed ID: 11435456
[TBL] [Abstract][Full Text] [Related]
51. Proliferation and remodeling of the peritubular microcirculation after nephron reduction: association with the progression of renal lesions.
Pillebout E; Burtin M; Yuan HT; Briand P; Woolf AS; Friedlander G; Terzi F
Am J Pathol; 2001 Aug; 159(2):547-60. PubMed ID: 11485913
[TBL] [Abstract][Full Text] [Related]
52. Vascular endothelial growth factor and its receptors.
Klagsbrun M; D'Amore PA
Cytokine Growth Factor Rev; 1996 Oct; 7(3):259-70. PubMed ID: 8971481
[TBL] [Abstract][Full Text] [Related]
53. Vascular endothelial growth factor (VEGF)-induced angiogenesis in herniated disc resorption.
Haro H; Kato T; Komori H; Osada M; Shinomiya K
J Orthop Res; 2002 May; 20(3):409-15. PubMed ID: 12038611
[TBL] [Abstract][Full Text] [Related]
54. Correlation of VEGF expression by leukocytes with the growth and regression of blood vessels in the rat cornea.
Edelman JL; Castro MR; Wen Y
Invest Ophthalmol Vis Sci; 1999 May; 40(6):1112-23. PubMed ID: 10235544
[TBL] [Abstract][Full Text] [Related]
55. Role of vascular endothelial growth factor in blood-brain barrier breakdown and angiogenesis in brain trauma.
Nag S; Takahashi JL; Kilty DW
J Neuropathol Exp Neurol; 1997 Aug; 56(8):912-21. PubMed ID: 9258261
[TBL] [Abstract][Full Text] [Related]
56. Connective tissue growth factor binds vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis.
Inoki I; Shiomi T; Hashimoto G; Enomoto H; Nakamura H; Makino K; Ikeda E; Takata S; Kobayashi K; Okada Y
FASEB J; 2002 Feb; 16(2):219-21. PubMed ID: 11744618
[TBL] [Abstract][Full Text] [Related]
57. Role of vascular endothelial growth factor in the response to vessel injury.
Alvarez Arroyo MV; Caramelo C; Angeles Castilla M; González Pacheco FR; Martín O; Arias J
Kidney Int Suppl; 1998 Dec; 68():S7-9. PubMed ID: 9839275
[TBL] [Abstract][Full Text] [Related]
58. SiRNA-mediated inhibition of vascular endothelial growth factor severely limits tumor resistance to antiangiogenic thrombospondin-1 and slows tumor vascularization and growth.
Filleur S; Courtin A; Ait-Si-Ali S; Guglielmi J; Merle C; Harel-Bellan A; Clézardin P; Cabon F
Cancer Res; 2003 Jul; 63(14):3919-22. PubMed ID: 12873985
[TBL] [Abstract][Full Text] [Related]
59. Expresson of vascular endothelial growth factor, its receptors (FLT-1, KDR) and TSP-1 related to microvessel density and patient outcome in vertical growth phase melanomas.
Straume O; Akslen LA
Am J Pathol; 2001 Jul; 159(1):223-35. PubMed ID: 11438469
[TBL] [Abstract][Full Text] [Related]
60. The role of vascular endothelial growth factor (VEGF) in renal pathophysiology.
Schrijvers BF; Flyvbjerg A; De Vriese AS
Kidney Int; 2004 Jun; 65(6):2003-17. PubMed ID: 15149314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
